Supplier News

The latest supplier news from Healthcare Packaging

Lippke/Mocon Announces Permeation, Sterile Medical Packaging Conferences

Two new one-day packaging conferences have been announced by Paul Lippke Handels-GmbH, Neuwied, Germany, a wholly-owned division of MOCON, Inc. (NASDAQ: MOCO), Minneapolis, Minn., USA.

February 1, 2011

Nutraceuticals/Dietary

Accuristix Acquires Nova Pack Limited

Accuristix is proud to announce the acquisition of Nova Pack Ltd., a contract packaging (co-pack ), re-packaging and assembly provider specializing in over-the-counter (OTC), health and beauty (HABA) , healthcare and pharmaceutical product handling. Combined with the current Accuristix customized healthcare logistics solutions, the acquisition enables enhanced outsourced co-pack capabilities and allows both companies to offer a broader scope of services to the Canadian healthcare marketplace.

January 30, 2011

Traceability/Serialization

COVECTRA offers serialization gateway for contract service providers

COVECTRA, a multi-layered brand protection solutions provider offering serialization, authentication, and track and trace technology services, today announced its new offering for Contract Service Providers (CSP) working in the pharmaceutical space.

January 26, 2011

Home

H.B. Fuller Hires Michael Olejnik to Expand Flexible Packaging Team

H.B. Fuller Company continues to demonstrate its commitment to the flexible packaging industry with the addition of Michael Olejnik as business development manager. Olejnik brings more than 25 years of flexible packaging knowledge and experience to H.B. Fuller. Olejnik held positions in sales and marketing management at Exopack Canada and Genpak. He also worked for Mobil Chemical and BI-AX International, where he developed strategic laminations instrumental in developing business for key packaging customers.

January 10, 2011

Home

Colorpak signs sale agreement to acquire Carter Holt Harey's folding carton business

Colorpak Limited (Colorpak) announces that it has completed due diligence and signed relevant agreements with Carter Holt Harvey (“CHH”) for the purchase of the folding carton businesses conducted at Reservoir and Mount Waverley in Victoria, Villawood in NSW and Auckland in New Zealand for a total consideration of AUD $5.0 million.

January 7, 2011

Regulatory

November 2010 Safety Labeling Changes: 37 Medical Product Labels with changes to Warnings, Contraindications, Precautions, Adverse Reactions

The MedWatch November 2010 Safety Labeling Changes posting includes 37 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and MEDICATION GUIDE.

December 30, 2010

Home

Merck Names Keller Crescent 'Supplier of the Year'

Merck, Las Piedras, Puerto Rico, has selected Keller Crescent as a 2010 Supplier of the Year.

December 28, 2010

Regulatory

Man Up Now Capsules: Consumer Warning - Undeclared Drug Ingredient

FDA warned consumers not to use Man Up Now capsules, marketed as a dietary supplement for sexual enhancement, because FDA analysis determined that the product contains sulfoaildenafil, a chemical similar to sildenafil, the active ingredient in Viagra. Like sildenafil, this chemical may interact with prescription drugs such as nitrates, including nitroglycerin, and cause dangerously low blood pressure.

December 15, 2010

Nutraceuticals/Dietary

Reese Pharmaceutical Company OTC Products: Recall - Mislabeled Guaifenesin Tablets

Refenesen Expectorant (guaifenesin 200 mg tablets) Select Brand Mucus Relief Expectorant (guaifenesin 200 mg) QC Medifin Expectorant (guaifenesin 200 mg) Leader Cough Tabs Expectorant (guaifenesin 200 mg)

December 15, 2010

Home

Merck Names Keller Crescent 'Supplier of the Year'

Merck, Las Piedras, Puerto Rico, has selected Keller Crescent as a 2010 Supplier of the Year.

December 14, 2010

Regulatory

B. Braun addEASE Binary Connector: Class I Recall -Stopper Fragments May Enter Bag

When the addEASE binary connector is inserted into a partial additive bag (PAB) stopper, fragments of the stopper may enter the bag, resulting in a small amount of visible particles in the solution.

December 1, 2010

Regulatory

October 2010 Safety Labeling Changes: 34 Medical Product Labels with changes to Boxed Warnings, Contraindications, Precautions, Adverse Reactions

The MedWatch October 2010 Safety Labeling Changes posting includes 34 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and MEDICATION GUIDE.

November 29, 2010

Regulatory

MOCON receives Packaging World's leader in packaging honor

MOCON, Inc. has just received a leadership honor from Packaging World magazine in the inspection/testing category.

October 27, 2010

Home

Bemis Wins 2010 Leadership in Packaging Award For Flexible Packaging

Bemis Company has won the Packaging World Leadership in Packaging award for 2010.

October 27, 2010

Regulatory

GnRH Agonists: Label Change - Increased Risk of Diabetes and Cardiovascular Disease

Gonadotropin-Releasing Hormone (GnRH) agonists will have new safety information added to the Warnings and Precautions section of the drug labels.

October 27, 2010

Materials

Catalent receives award for its innovative combination potent product launch partnership with a top 5 multi-national pharma company

Catalent Pharma Solutions has won for the third year in a row "The Best Contract Manufacturing Project" award at the 2010 European Outsourcing Awards, again recognizing its industry leadership and excellence.

October 27, 2010

Regulatory

September 2010 Safety Labeling Changes: 37Medical Product Labels with changes to Warnings, Contraindications,Precautions, Adverse Reactions

The MedWatch September 2010 Safety Labeling Changes posting includes 37 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and MEDICATION GUIDE.

October 21, 2010

Regulatory

Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm

FDA notified healthcare professionals of new risk information added to the Warnings and Precautions, Contraindications, and Clinical Pharmacology sections of the antiviral drug Invirase (saquinavir), describing a potential change in the electrical activity of the heart when Invirase is used with another antiviral medication, Norvir (ritonavir).

October 21, 2010

Page 94 of 97